<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schub D</submitter><funding>Dr. Rolf M. Schwiete Stiftung</funding><funding>Universität des Saarlandes</funding><funding>State of Saarland</funding><pagination>142167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7605520</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(20)</volume><pubmed_abstract>BACKGROUNDPatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS-CoV-2-specific immunity correlate with disease severity.METHODSIn this study, SARS-CoV-2-specific T cells and antibodies were characterized in uninfected controls and patients with different coronavirus disease 2019 (COVID-19) disease severity. SARS-CoV-2-specific T cells were flow cytometrically quantified after stimulation with SARS-CoV-2 peptide pools and analyzed for expression of cytokines (IFN-γ, IL-2, and TNF-α) and markers for activation, proliferation, and functional anergy. SARS-CoV-2-specific IgG and IgA antibodies were quantified using ELISA. Moreover, global characteristics of lymphocyte subpopulations wer</pubmed_abstract><journal>JCI insight</journal><pubmed_title>High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.</pubmed_title><pmcid>PMC7605520</pmcid><funding_grant_id>no number</funding_grant_id><pubmed_authors>Sester M</pubmed_authors><pubmed_authors>Schub D</pubmed_authors><pubmed_authors>Klemis V</pubmed_authors><pubmed_authors>Bals R</pubmed_authors><pubmed_authors>Schneitler S</pubmed_authors><pubmed_authors>Sester U</pubmed_authors><pubmed_authors>Lepper PM</pubmed_authors><pubmed_authors>Mihm J</pubmed_authors><pubmed_authors>Wilkens H</pubmed_authors><pubmed_authors>Eichler H</pubmed_authors><pubmed_authors>Schmidt T</pubmed_authors><pubmed_authors>Gartner BC</pubmed_authors><pubmed_authors>Becker SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.</name><description>BACKGROUNDPatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS-CoV-2-specific immunity correlate with disease severity.METHODSIn this study, SARS-CoV-2-specific T cells and antibodies were characterized in uninfected controls and patients with different coronavirus disease 2019 (COVID-19) disease severity. SARS-CoV-2-specific T cells were flow cytometrically quantified after stimulation with SARS-CoV-2 peptide pools and analyzed for expression of cytokines (IFN-γ, IL-2, and TNF-α) and markers for activation, proliferation, and functional anergy. SARS-CoV-2-specific IgG and IgA antibodies were quantified using ELISA. Moreover, global characteristics of lymphocyte subpopulations wer</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-06-01T03:53:20.838Z</modification><creation>2025-06-01T03:53:20.838Z</creation></dates><accession>S-EPMC7605520</accession><cross_references><pubmed>32937615</pubmed><doi>10.1172/jci.insight.142167</doi></cross_references></HashMap>